Published in Cancer on February 15, 1993
Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet (2002) 5.06
Malignant peripheral nerve sheath tumors (MPNST)--clinicopathological study and treatment outcome of twenty-four cases. World J Surg Oncol (2006) 2.58
Head and neck sarcomas: the UCLA experience. Am J Otolaryngol (2014) 1.96
Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1. J Med Genet (2007) 1.12
Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours. Sarcoma (2009) 1.10
High-resolution ultrasound of peripheral neurogenic tumors. Eur Radiol (2007) 1.04
Malignant peripheral nerve sheath tumours in inherited disease. Clin Sarcoma Res (2012) 1.03
Malignant peripheral nerve sheath tumor associated with neurofibromatosis type 1, with metastasis to the heart: a case report. Diagn Pathol (2010) 0.96
Malignant peripheral nerve sheath tumor of the orbit: case report and literature review. Skull Base (2004) 0.95
Neoplasms associated with germline and somatic NF1 gene mutations. Oncologist (2012) 0.95
Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Front Oncol (2014) 0.94
Sonographic evaluation of brachial plexus pathology. Eur Radiol (2003) 0.92
Retroperitoneal peripheral nerve sheath tumour of triton type-a case report. Indian J Surg (2011) 0.88
Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors. BMC Med (2013) 0.88
Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development. Dis Model Mech (2012) 0.88
Advanced epithelioid malignant peripheral nerve sheath tumor showing complete response to combined surgery and chemotherapy: a case report. Case Rep Oncol Med (2011) 0.84
Malignant peripheral nerve sheath tumors presenting as spinal dumbbell tumors: clinical outcomes and characteristic imaging features. Eur Spine J (2015) 0.83
Brachial plexus tumors in a consecutive series of twenty one patients. J Korean Neurosurg Soc (2012) 0.82
Malignant Triton tumor in the retroperitoneal space associated with neurofibromatosis type 1: a case study. Rare Tumors (2009) 0.81
Hyaluronan expression as a significant prognostic factor in patients with malignant peripheral nerve sheath tumors. Clin Exp Metastasis (2014) 0.80
Differential expression of angiogenic factors in peripheral nerve sheath tumors. Clin Exp Metastasis (2008) 0.79
Malignant Peripheral Nerve Sheath Tumor Presenting as a Massive Intra-abdominal Mass. Med J Armed Forces India (2011) 0.79
Primary paraspinal malignant peripheral nerve sheath tumor. J Korean Neurosurg Soc (2008) 0.79
Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors. Onco Targets Ther (2013) 0.79
Malignant peripheral nerve sheath tumors of the head and neck: a case series and literature review. Case Rep Otolaryngol (2014) 0.79
Excellent response of malignant peripheral nerve sheath tumour of retroperitoneum to radiation therapy. BMJ Case Rep (2012) 0.79
Peripheral Nerve Sheath Tumors of the Thyroid Gland: A Series of Four Cases and a Review of the Literature. Endocr Pathol (1996) 0.79
Malignant peripheral nerve sheath tumour of the renal parenchyma presenting as a fast growing atypical renal cyst. Can Urol Assoc J (2013) 0.78
Malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1. Case Rep Oncol Med (2014) 0.78
Early-stage malignant peripheral nerve sheath tumour arising from a solitary neurofibroma. Br J Radiol (2012) 0.77
Carbon Ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheaths tumors: acute toxicity and preliminary outcome. Radiat Oncol (2015) 0.77
Malignant Peripheral Nerve Sheath Tumors: A Single Institution's Experience Using Combined Surgery and Radiation Therapy. Am J Clin Oncol (2016) 0.75
Giant intrapelvic malignant peripheral nerve sheath tumor mimicking disc herniation: A case report. Mol Clin Oncol (2016) 0.75
Long-term progress of six cases of malignant peripheral nerve sheath tumors of the mediastinum that underwent surgical treatment: Case report series. Int J Surg Case Rep (2016) 0.75
A rare case of recurrent malignant triton tumor in a male with NF1: Case report and mini-review. Int J Surg Case Rep (2016) 0.75
Pulmonary metastases: a rare cause for pulmonary artery invasion and in situ pulmonary artery thrombosis-demonstration with multidetector computed tomography. Med J Armed Forces India (2012) 0.75
Malignant peripheral nerve sheath tumors in Africa: a clinicopathological study. ISRN Surg (2011) 0.75
Malignant peripheral nerve sheath tumor in spine: Two case reports. South Asian J Cancer (2013) 0.75
[Specificity of sarcomatous transformation in Recklinghaussen disease: a report of two cases and review of the literature]. Pan Afr Med J (2013) 0.75
Giant malignant peripheral nerve sheath tumor with cauda equina syndrome and subarachnoid hemorrhage: Complications in a case of type 1 neurofibromatosis. J Nat Sci Biol Med (2015) 0.75
Microsurgical management of giant malignant peripheral nerve sheath tumor of the scalp: two case reports and a literature review. World J Surg Oncol (2013) 0.75
Coexistent malignant peripheral nerve sheath tumor and lateral spinal meningoceles. J Surg Tech Case Rep (2012) 0.75
Malignant Peripheral Nerve Sheath Tumour of the Small Bowel Presenting with Intussusception and Perforation: a Double Jeopardy? Indian J Surg Oncol (2016) 0.75
Orthopaedic case of the month: A 14-year-old boy with a medial thigh soft tissue mass. Clin Orthop Relat Res (2013) 0.75
Malignant Peripheral Nerve Sheath Tumour of the Male Breast with Nodal Metastasis. Indian J Surg Oncol (2015) 0.75
Malignant nerve sheath tumor involving glossopharyngeal, vagus and spinal nerve with intracranial-extracranial extension and systemic metastases in a patient with type 1 neurofibromatosis: A case report. Int J Surg Case Rep (2016) 0.75
Primary hepatic malignant peripheral nerve sheath tumor successfully treated with combination therapy: a case report and literature review. Ann Surg Treat Res (2016) 0.75
Concurrence of malignant peripheral nerve sheath tumor at the site of complex regional pain syndrome type 1 - a case report -. Korean J Pain (2013) 0.75
Role of ultrasonography in detection of renal artery pseudoaneurysm caused by retroperitoneal malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1. J Med Ultrason (2001) (2013) 0.75
Younger women with breast carcinoma have a poorer prognosis than older women. Cancer (1996) 3.54
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci U S A (1996) 3.38
Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26
Symptom assessment in schizophrenic prodromal states. Psychiatr Q (1999) 3.09
Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med (1978) 2.69
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum (1994) 2.04
Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer (1995) 1.97
The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88
Proceedings: Treatment of minimal breast cancer. Cancer (1974) 1.78
Anorectal melanoma. Cancer (1981) 1.77
Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg (1996) 1.77
Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain. Science (1966) 1.65
The surgical treatment of fibrous dysplasia. With emphasis on recent contributions from cranio-maxillo-facial surgery. Ann Surg (1985) 1.58
Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52
Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg (1978) 1.49
Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am J Pathol (1992) 1.47
Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum (1978) 1.44
T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg (1975) 1.40
Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev Dyn (1993) 1.31
Immunogenic properties of reticulum cell sarcomas of SJL/J mice. J Natl Cancer Inst (1970) 1.30
Galeal-pericranial flaps in head and neck reconstruction. Anatomy and application. Am J Surg (1984) 1.30
Diagnosis and management of giant intrasacral schwannoma. Cancer (1992) 1.28
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27
Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg (1995) 1.24
Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg (1985) 1.22
Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22
Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study. Acta Neuropathol (1995) 1.21
Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131) Ann Surg (1994) 1.21
In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms. Am J Pathol (1998) 1.21
Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer (1993) 1.20
Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum (1983) 1.19
Craniofacial growth following experimental craniosynostosis and craniectomy in rabbits. J Neurosurg (1979) 1.18
Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg (1981) 1.16
Cranial vault growth in craniosynostosis. J Neurosurg (1989) 1.11
Immunologic reactivity in patients with primary operable breast cancer. Cancer (1978) 1.10
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. J Clin Oncol (1987) 1.08
Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg (1987) 1.07
An experimental mouse testicular teratoma as a model for neuroepithelial neoplasia and differentiation. I. Light microscopic and tissue and organ culture observations. Am J Pathol (1975) 1.05
Is carcinoma of the gallbladder a curable lesion? Ann Surg (1982) 1.05
Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. J Cell Sci (2001) 1.04
Biomaterials in the face: benefits and risks. J Craniofac Surg (1999) 1.03
Pelvic exenteration for recurrent rectal cancer. Adv Surg (1996) 1.02
Craniofacial trauma: an assessment of risk related to timing of surgery. Plast Reconstr Surg (1990) 1.01
Dysembryoplastic neuroeptihelial tumor (DNT): an immunohistochemical and ultrastructural study. J Neuropathol Exp Neurol (1994) 1.01
Variants of sagittal synostosis: strategies for surgical correction. J Neurosurg (1984) 1.00
Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? Surgery (1981) 1.00
ERK/MAP kinase is chronically activated in human reactive astrocytes. Neuroreport (1999) 1.00
Barrel stave osteotomy for correction of turribrachycephaly craniosynostosis deformity. Ann Plast Surg (1987) 0.99
Pleural mesothelioma. Cancer (1976) 0.99
Calvarial deformity regeneration following subtotal craniectomy for craniosynostosis: a case report and theoretical implications. J Craniofac Surg (1993) 0.99
Multiple recurrent benign schwannomas of deep and superficial nerves of the upper extremity: a new variant of segmental neurofibromatosis. Ann Plast Surg (1994) 0.98
Lidocaine or thiopental for rapid control of intracranial hypertension? Anesth Analg (1980) 0.98
Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg (1992) 0.97
Phorbol 12-myristate 13-acetate induces protein kinase ceta-specific proliferative response in astrocytic tumor cells. J Biol Chem (2000) 0.97
Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg (1993) 0.97
Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathol (1996) 0.96
The acute and chronic effects of alcohol on the human immune system. Surg Gynecol Obstet (1975) 0.96
The craniofacial resection--eleven-year experience at the University of Virginia: problems and solutions. Otolaryngol Head Neck Surg (1989) 0.96
Fine needle aspiration cytology in lieu of open biopsy in management of primary breast cancer. Ann Surg (1984) 0.96
Surgical management and treatment of gastric and duodenal fistulas. Surg Clin North Am (1996) 0.96
Ganglioglioma: an ultrastructural and immunohistochemical study. Cancer (1997) 0.96
Thyroid cancer: some basic considerations. Am J Surg (1981) 0.95
Expression of developmentally defined retinal phenotypes in the histogenesis of retinoblastoma. Am J Pathol (1992) 0.95
Immune reactivity in patients with colorectal cancer: assessment of biologic risk by immunoparameters. Cancer (1980) 0.95
Rectal injuries. J Trauma (1969) 0.94
Prognostic evaluation of regional lymph node morphology colorectal cancer. Am J Surg (1975) 0.93
Low density lipoprotein receptor-related protein is expressed early and becomes restricted to a somatodendritic domain during neuronal differentiation in culture. Brain Res (1997) 0.92
Surgical adjuvant therapy of malignant melanoma with corynebacterium parvum. Cancer (1981) 0.92
Thin < or = 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy. Ann Surg Oncol (2000) 0.92
Fluoxetine and the bleeding time. Arch Pathol Lab Med (1990) 0.92
Maturation of intracranial immature teratomas. Report of two cases. J Neurosurg (1996) 0.92
Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. Am J Pathol (1994) 0.92
Intravenous Corynebacterium parvum: an adjunct to chemotherapy for resistant advanced ovarian cancer. Cancer (1977) 0.91
Multiple sclerosis and brain tumor: a diagnostic challenge. J Emerg Med (1989) 0.91
The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg (1997) 0.91
Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients. Cancer (1986) 0.91
Immunologic reactivity and prognosis in breast cancer. Cancer (1980) 0.91
Colonoscopy: an essential monitoring technique after resection of colorectal cancer. Am J Surg (1983) 0.91
Localized carcinoma of the external ear is an unrecognized aggressive disease with a high propensity for local regional recurrence. Am J Surg (1992) 0.90
Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer. Am J Surg (1995) 0.90
Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer (1985) 0.90
Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas. Neuro Oncol (1999) 0.90
Cytoskeletal immunohistochemistry of central neurocytomas. Am J Surg Pathol (1992) 0.90
Transcriptional regulation of LDL receptor-related protein by IFN-gamma and the antagonistic activity of TGF-beta(1) in the RAW 264.7 macrophage-like cell line. J Leukoc Biol (1996) 0.89
Surgical approaches for the correction of metopic synostosis. Neurosurgery (1986) 0.89
Experimental unilateral coronal synostosis in rabbits. Plast Reconstr Surg (1986) 0.89
Prefrontal cortical blood flow and cognitive function in Huntington's disease. J Neurol Neurosurg Psychiatry (1988) 0.89
Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol (1998) 0.89
Squamous cell carcinoma in the immunosuppressed patient: Fanconi's anemia. Laryngoscope (1985) 0.89
Intracranial pressure in single-suture craniosynostosis. Cleft Palate Craniofac J (1998) 0.89
Late surgical treatment of unilateral coronal synostosis using methyl methacrylate. J Neurosurg (1987) 0.88
Plasminogen binding to rat hepatocytes in primary culture and to thin slices of rat liver. Blood (1989) 0.88
Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein is increased in reactive and neoplastic glial cells. FEBS Lett (1994) 0.88
Prognostic analysis of survival in small breast cancers. J Am Coll Surg (1998) 0.88
Multimodality approach to surgical management of locally advanced epidermoid carcinoma of the anorectum. Cancer (1981) 0.87